» Articles » PMID: 29136627

Toll-Like Receptor 4 Reduces Occludin and Zonula Occludens 1 to Increase Retinal Permeability Both in Vitro and in Vivo

Overview
Journal J Vasc Res
Date 2017 Nov 15
PMID 29136627
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

We reported that β-adrenergic receptors regulate toll-like receptor 4 (TLR4) signaling in the retina of diabetic mice and in retinal endothelial cells (REC) and Müller cells. We hypothesized that TLR4 regulates retinal permeability both in vitro and in vivo in the retinal vasculature. We used REC cultured in normal and high-glucose conditions and TLR4 siRNA treatments for cell culture studies of permeability and protein analyses of tumor necrosis factor α, occludin, and zonula occludens 1 (ZO-1). We used endothelial cell (EC)-specific Cre-Lox TLR4 knockout mice to study retinal permeability and neuronal and vascular changes following exposure to ocular ischemia/reperfusion (I/R) used as a retinal stressor. We found that the loss of TLR4 in the EC led to the reduced permeability following I/R and fewer degenerate capillaries. Retinal permeability was increased in REC grown in high-glucose conditions but was inhibited by TLR4 siRNA treatment. High-glucose culture conditions significantly reduced occludin and ZO-1 levels in REC, and TLR4 siRNA treatment restored levels to baseline. In conclusion, these studies demonstrate that TLR4 in EC strongly regulates retinal permeability and neuronal and vascular changes following exposure to stressors such as I/R.

Citing Articles

Toll-Like Receptor Signalling Pathways and the Pathogenesis of Retinal Diseases.

Titi-Lartey O, Mohammed I, Amoaku W Front Ophthalmol (Lausanne). 2024; 2:850394.

PMID: 38983565 PMC: 11182157. DOI: 10.3389/fopht.2022.850394.


Shedding light on the molecular and regulatory mechanisms of TLR4 signaling in endothelial cells under physiological and inflamed conditions.

Stierschneider A, Wiesner C Front Immunol. 2023; 14:1264889.

PMID: 38077393 PMC: 10704247. DOI: 10.3389/fimmu.2023.1264889.


Epac1 and PKA agonists inhibit ROS to reduce NLRP3 inflammasome proteins in retinal endothelial cells.

Liu L, Jiang Y, Steinle J Mol Vis. 2023; 28:500-506.

PMID: 37089701 PMC: 10115359.


Loss of cystatin C regulates permeability and inflammatory pathways in retina.

Liu L, Jiang Y, Steinle J Microvasc Res. 2023; 148:104510.

PMID: 36822364 PMC: 10258155. DOI: 10.1016/j.mvr.2023.104510.


MicroRNA-based engineering of mesenchymal stem cell extracellular vesicles for treatment of retinal ischemic disorders: Engineered extracellular vesiclesand retinal ischemia.

Mathew B, Acha L, Torres L, Huang C, Liu A, Kalinin S Acta Biomater. 2023; 158:782-797.

PMID: 36638942 PMC: 10005109. DOI: 10.1016/j.actbio.2023.01.014.


References
1.
Mir H, Meena A, Chaudhry K, Shukla P, Gangwar R, Manda B . Occludin deficiency promotes ethanol-induced disruption of colonic epithelial junctions, gut barrier dysfunction and liver damage in mice. Biochim Biophys Acta. 2016; 1860(4):765-74. PMC: 4776745. DOI: 10.1016/j.bbagen.2015.12.013. View

2.
Abcouwer S, Lin C, Shanmugam S, Muthusamy A, Barber A, Antonetti D . Minocycline prevents retinal inflammation and vascular permeability following ischemia-reperfusion injury. J Neuroinflammation. 2013; 10:149. PMC: 3866619. DOI: 10.1186/1742-2094-10-149. View

3.
Liu L, Jiang Y, Curtiss E, Fukuchi K, Steinle J . TLR4 regulates insulin-resistant proteins to increase apoptosis in the mouse retina. Inflamm Res. 2017; 66(11):993-997. PMC: 5896291. DOI: 10.1007/s00011-017-1080-0. View

4.
Kern T, Miller C, Du Y, Zheng L, Mohr S, Ball S . Topical administration of nepafenac inhibits diabetes-induced retinal microvascular disease and underlying abnormalities of retinal metabolism and physiology. Diabetes. 2007; 56(2):373-9. DOI: 10.2337/db05-1621. View

5.
Wang H, Shi H, Zhang J, Wang G, Zhang J, Jiang F . Toll-like receptor 4 in bone marrow-derived cells contributes to the progression of diabetic retinopathy. Mediators Inflamm. 2014; 2014:858763. PMC: 4156976. DOI: 10.1155/2014/858763. View